antidepressant therapy

Repressive Epigenetic Changes at the Mglu2 Promoter in Frontal Cortex of 5-HT2A Knockout Mice.

Published March 20, 2013

Repressive Epigenetic Changes at the Mglu2 Promoter in Frontal Cortex of 5-HT2A Knockout Mice.

Mol Pharmacol. 2013 Mar 18;
Kurita M, Moreno JL, Holloway T, Kozlenkov A, Mocci G, Garcia-Bea A, Hanks JB, Neve R, Nestler EJ, Russo SJ,… Continue reading →

[Social and Economic Consequences of Night-Time Aircraft Noise in the Vicinity of Frankfurt/Main Airport.]

Published March 5, 2013

[Social and Economic Consequences of Night-Time Aircraft Noise in the Vicinity of Frankfurt/Main Airport.]

Gesundheitswesen. 2013 Mar 1;
Greiser E, Glaeske G

A prospective calculation of disease-related social and economic costs due to night-time aircraft noise in the vicinity… Continue reading →

Depression Treatment: Ketamin for the Treatment of Depression.

Published February 16, 2013

Ketamin for the treatment of depression.

Filed under: Depression Treatment

J Psychosoc Nurs Ment Health Serv. 2013 Jan; 51(1): 11-4
Howland RH

Ketamine (Ketalar®) is an anesthetic agent derived from the hallucinogenic drug phencyclidine (PCP). It is a high-affinity… Continue reading →

Depression Treatment: Nutrition and Depression at the Forefront of Progress.

Published January 25, 2013

Nutrition and depression at the forefront of progress.

Filed under: Depression Treatment

J Med Life. 2012 Dec 15; 5(4): 414-9
Popa T, Ladea M

Depression is a debilitating disorder estimated to become the second cause of morbidity worldwide by… Continue reading →

Acute Antidepressive Efficacy of Lithium Monotherapy, Not Citalopram, Depends on Recurrent Course of Depression.

Published January 3, 2013

Acute Antidepressive Efficacy of Lithium Monotherapy, Not Citalopram, Depends on Recurrent Course of Depression.

Filed under: Depression Treatment

J Clin Psychopharmacol. 2012 Dec 28;
Bschor T, Uhr M, Baethge C, Lewitzka U, Ising M, Erbe S, Winkelmann P, Ritter… Continue reading →

Treatment Acceptance and Adherence in HIV Disease: Patient Identity and the Perceived Impact of Physician-Patient Communication.

Published December 29, 2012

Treatment acceptance and adherence in HIV disease: patient identity and the perceived impact of physician-patient communication.

Filed under: Addiction Rehab

Patient Prefer Adherence. 2012; 6: 893-903
Laws MB, Rose GS, Bezreh T, Beach MC, Taubin T, Kogelman L, Gethers… Continue reading →

General Practitioners’ Choices and Their Determinants When Starting Treatment for Major Depression: A Cross Sectional, Randomized Case-Vignette Survey.

Published December 29, 2012

General practitioners’ choices and their determinants when starting treatment for major depression: a cross sectional, randomized case-vignette survey.

Filed under: Depression Treatment

PLoS One. 2012; 7(12): e52429
Dumesnil H, Cortaredona S, Verdoux H, Sebbah R, Paraponaris A, Verger P… Continue reading →

Depression Treatment: Vesicular Signalling and Immune Modulation as Hedonic Fingerprints: Proteomic Profiling in the Chronic Mild Stress Depression Model.

Published November 10, 2012

Vesicular signalling and immune modulation as hedonic fingerprints: proteomic profiling in the chronic mild stress depression model.

Filed under: Depression Treatment

J Psychopharmacol. 2012 Nov 8;
Bisgaard CF, Bak S, Christensen T, Jensen ON, Enghild JJ, Wiborg O

Extensive… Continue reading →

Primary Care-Mental Health Integration Programs in the Veterans Affairs Health System Serve a Different Patient Population Than Specialty Mental Health Clinics.

Published October 30, 2012

Primary care-mental health integration programs in the veterans affairs health system serve a different patient population than specialty mental health clinics.

Filed under: Depression Treatment

Prim Care Companion CNS Disord. 2012; 14(3):
Johnson-Lawrence VD, Szymanski BR, Zivin K, McCarthy… Continue reading →

Depression Treatment: Effect of Selective Serotonin Reuptake Inhibitors in Alzheimer’s Disease With Comorbid Depression : A Meta-Analysis of Depression and Cognitive Outcomes.

Published October 22, 2012

Effect of selective serotonin reuptake inhibitors in Alzheimer’s disease with comorbid depression : a meta-analysis of depression and cognitive outcomes.

Filed under: Depression Treatment

Drugs Aging. 2012 Oct; 29(10): 793-806
Sepehry AA, Lee PE, Hsiung GY, Beattie BL, Jacova… Continue reading →

[Social and Economic Consequences of Night-Time Aircraft Noise in the Vicinity of Frankfurt/Main Airport.]

Depression Treatment: Ketamin for the Treatment of Depression.

Depression Treatment: Nutrition and Depression at the Forefront of Progress.

Acute Antidepressive Efficacy of Lithium Monotherapy, Not Citalopram, Depends on Recurrent Course of Depression.

Treatment Acceptance and Adherence in HIV Disease: Patient Identity and the Perceived Impact of Physician-Patient Communication.

Depression Treatment: Vesicular Signalling and Immune Modulation as Hedonic Fingerprints: Proteomic Profiling in the Chronic Mild Stress Depression Model.

Recent Posts

Search this Site